Literature DB >> 33229260

Subacute toxicity of mesoporous silica nanoparticles to the intestinal tract and the underlying mechanism.

Yu-Di Deng1, Xu-Dong Zhang1, Xu-Shan Yang1, Zhen-Lie Huang2, Xi Wei1, Xing-Fen Yang3, Wen-Zhen Liao4.   

Abstract

The biological safety of mesoporous silica nanoparticles (MSNs) has gradually attracted attention. However, few studies of their toxicity to the intestine and mechanism are available. In this study, their primary structures were characterized, and their subacute toxicity to mice was investigated. After 2 weeks of intragastric administration of MSNs, they significantly enhanced serum ALP, ALT, AST and TNF-α levels and caused infiltration of inflammatory cells in the spleen and intestines. MSNs induced intestinal oxidative stress and colonic epithelial cell apoptosis in mice. Intestinal epithelial cells exhibited mitochondrial ridge rupture and membrane potential decrease after MSN treatment. Additionally, MSNs increased ROS and NLRP3 levels and inhibited expression of the autophagy proteins LC3-II and Beclin1. MSNs significantly changed the intestinal flora diversity in mice, especially for harmful bacteria, leading to intestinal microecology imbalance. Meanwhile, MSNs influenced the expression of metabolites, which were involved in a range of metabolic pathways, including pyrimidine metabolism, central carbon metabolism in cancer, protein digestion and absorption, mineral absorption, ABC transport and purine metabolism. These results indicated that the subacute toxicity of mesoporous silicon was mainly caused by intestinal damage. Thus, our research provides additional evidence about the safe dosage of MSNs in the clinical and food industries.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Intestinal flora; Mesoporous silica nanoparticles; Metabolomics; Oral exposure; Subacute Toxicity

Mesh:

Substances:

Year:  2020        PMID: 33229260     DOI: 10.1016/j.jhazmat.2020.124502

Source DB:  PubMed          Journal:  J Hazard Mater        ISSN: 0304-3894            Impact factor:   10.588


  7 in total

1.  Influence of Critical Parameters on Cytotoxicity Induced by Mesoporous Silica Nanoparticles.

Authors:  Amirsadra Ahmadi; Moses Sokunbi; Trisha Patel; Ming-Wei Chang; Zeeshan Ahmad; Neenu Singh
Journal:  Nanomaterials (Basel)       Date:  2022-06-11       Impact factor: 5.719

2.  Oral Toxicokinetics, Tissue Distribution, and 28-Day Oral Toxicity of Two Differently Manufactured Food Additive Silicon Dioxides.

Authors:  Na-Kyung Yoo; Su-Min Youn; Soo-Jin Choi
Journal:  Int J Mol Sci       Date:  2022-04-05       Impact factor: 5.923

Review 3.  Application of Mesoporous Silica Nanoparticles in Cancer Therapy and Delivery of Repurposed Anthelmintics for Cancer Therapy.

Authors:  Maedeh Koohi Moftakhari Esfahani; Seyed Ebrahim Alavi; Peter J Cabot; Nazrul Islam; Emad L Izake
Journal:  Pharmaceutics       Date:  2022-07-29       Impact factor: 6.525

Review 4.  Modulation of Gut Microbiota by Essential Oils and Inorganic Nanoparticles: Impact in Nutrition and Health.

Authors:  Veronica Lazar; Alina-Maria Holban; Carmen Curutiu; Lia Mara Ditu
Journal:  Front Nutr       Date:  2022-07-08

5.  The anti-tumor and renoprotection study of E-[c(RGDfK)2]/folic acid co-modified nanostructured lipid carrier loaded with doxorubicin hydrochloride/salvianolic acid A.

Authors:  Bing Zhang; Ying Zhang; Wenli Dang; Bin Xing; Changxiang Yu; Pan Guo; Jiaxin Pi; Xiuping Deng; Dongli Qi; Zhidong Liu
Journal:  J Nanobiotechnology       Date:  2022-09-24       Impact factor: 9.429

6.  Identification and Validation of Biglycan as Prognosis and Therapy Markers for Patients with Stomach Adenocarcinoma.

Authors:  Changming Shao; Chunfa Cheng; Qinshu Shao; Bing Chen
Journal:  Int J Gen Med       Date:  2021-07-15

7.  Global Proteomics to Study Silica Nanoparticle-Induced Cytotoxicity and Its Mechanisms in HepG2 Cells.

Authors:  Sun Young Lee; In Young Kim; Min Beom Heo; Jeong Hee Moon; Jin Gyeong Son; Tae Geol Lee
Journal:  Biomolecules       Date:  2021-03-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.